Literature DB >> 31127514

Could curcumin ameliorate titanium dioxide nanoparticles effect on the heart? A histopathological, immunohistochemical, and genotoxic study.

Eman Ahmed Alaa El-Din1, Heba El-Sayed Mostafa2, Mai A Samak3, Eman M Mohamed3, Dalia Abdallah El-Shafei4.   

Abstract

The evaluation of the toxicological effects of titanium dioxide nanoparticles (TiO2NPs) is increasingly important due to their growing occupational and industrial use. Curcumin is a yellow curry spice with a long history of use in herbal medicine and has numerous protective potentials such as antioxidant, antimicrobial, anti-inflammatory, and anti-apoptotic effects. Accordingly, we tested the hypothesis that curcumin could ameliorate TiO2NP-induced cardiotoxic and genotoxic effects in adult male albino rats. For this purpose, 48 adult male albino rats were randomized into five groups; all treatment was by oral gavage once daily for 90 days: group I (8 rats), untreated control; group II (16 rats), subdivided into vehicle control IIa (8 rats) received saline and vehicle control IIb (8 rats) received corn oil; group III (8 rats) orally gavaged with curcumin dissolved in 0.5 ml corn oil at a dose of 200 mg/kg b.w./day; group IV treated with TiO2NPs at a dose of 1200 mg/kg b.w./day (1/10 LD50) suspended in 1 ml of 0.9% saline; group V treated with curcumin + TiO2NPs (the same previously mentioned doses). Curcumin was orally gavaged for 7 days before TiO2NPs treatment was initiated, and then they received TiO2NPs along with curcumin at the same doses for 90 days. TiO2NPs administration resulted in several myocardial cytomorphic changes as structurally disorganized, degenerated, and apoptotic cardiomyocytes and the newly implemented 3-nitrotyrosine immune expression rendered strong evidence that these effects derived from the cardio myocellular oxidative burden. Furthermore, comet assay results confirmed TiO2NP-related DNA damage. Remarkably, all these changes are partially mitigated in rats treated with both curcumin and TiO2NPs. Our results suggest that concurrent curcumin treatment has a beneficial role in ameliorating TiO2NP-induced cardiotoxicity and this may be mediated by its antioxidative property.

Entities:  

Keywords:  3-Nitrotyrosine; Cardiomyocytes; Desmin; Genotoxicity; Nanoparticles; Titanium dioxide

Mesh:

Substances:

Year:  2019        PMID: 31127514     DOI: 10.1007/s11356-019-05433-2

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  3 in total

1.  Safety assessment of titanium dioxide (E171) as a food additive.

Authors:  Maged Younes; Gabriele Aquilina; Laurence Castle; Karl-Heinz Engel; Paul Fowler; Maria Jose Frutos Fernandez; Peter Fürst; Ursula Gundert-Remy; Rainer Gürtler; Trine Husøy; Melania Manco; Wim Mennes; Peter Moldeus; Sabina Passamonti; Romina Shah; Ine Waalkens-Berendsen; Detlef Wölfle; Emanuela Corsini; Francesco Cubadda; Didima De Groot; Rex FitzGerald; Sara Gunnare; Arno Christian Gutleb; Jan Mast; Alicja Mortensen; Agnes Oomen; Aldert Piersma; Veronika Plichta; Beate Ulbrich; Henk Van Loveren; Diane Benford; Margherita Bignami; Claudia Bolognesi; Riccardo Crebelli; Maria Dusinska; Francesca Marcon; Elsa Nielsen; Josef Schlatter; Christiane Vleminckx; Stefania Barmaz; Maria Carfí; Consuelo Civitella; Alessandra Giarola; Ana Maria Rincon; Rositsa Serafimova; Camilla Smeraldi; Jose Tarazona; Alexandra Tard; Matthew Wright
Journal:  EFSA J       Date:  2021-05-06

2.  Non-toxic doses of modified titanium dioxide nanoparticles (m-TiO2NPs) in albino CFW mice.

Authors:  Mónica Basante-Romo; Jose Oscar Gutiérrez-M; Rubén Camargo-Amado
Journal:  Heliyon       Date:  2021-03-16

Review 3.  Adverse Outcome Pathways Associated with the Ingestion of Titanium Dioxide Nanoparticles-A Systematic Review.

Authors:  Dora Rolo; Ricardo Assunção; Célia Ventura; Paula Alvito; Lídia Gonçalves; Carla Martins; Ana Bettencourt; Peter Jordan; Nádia Vital; Joana Pereira; Fátima Pinto; Paulo Matos; Maria João Silva; Henriqueta Louro
Journal:  Nanomaterials (Basel)       Date:  2022-09-21       Impact factor: 5.719

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.